TRIDENT study- Studying diabetic nephropathy using precision medicine.
Overview TRIDENT, aims to develop ground-breaking therapeutics for patients living with diabetic kidney disease (or diabetic nephropathy) via the use of next generation multi-omics and precision medicine approaches.
TRIDENT is a collaborative network of expert physicians, basic scientists, clinical researchers, and renal pathologists from 16 North American medical centers and three pharmaceutical companies devoted to improving the lives of those affected by diabetic kidney disease.
Biography Time
|